We are live on
!
Find out more
DBTX
Decibel Therapeutics, Inc. Common Stock
DBTX
DBTX
Delisted
DBTX was delisted on the 22nd of September, 2023.
1 hedge funds and large institutions have $36.4K invested in Decibel Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
83% more call options, than puts
Call options by funds: $11K | Put options by funds: $6K
97% less funds holding
Funds holding: 37 → 1 (-36)
100% less capital invested
Capital invested by funds: $59.2M → $36.4K (-$59.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 36
Holders
1
Holders Change
-36
Holders Change %
-97.3%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
36
Calls
$11K
Puts
$6K
Net Calls
+$5K
Net Calls Change
+$5K
Top Buyers
| 1 |
ACA
Atlas Capital Advisors
Jackson,
Wyoming
|
+$63K |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$19M |
| 2 |
TGI
TRV GP III
Boston,
Massachusetts
|
-$12.1M |
| 3 |
BlackRock
New York
|
-$6.97M |
| 4 |
AI
Alphabet Inc
Mountain View,
California
|
-$6.3M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$3.09M |
